A new approach to classifying malnutrition in the hemodialysis patient

被引:7
作者
O'Keefe, A
Daigle, NW
机构
[1] San Diego Dialysis Natl City, National City, CA 91950 USA
[2] San Diego Dialysis Chula Vista S, San Diego, CA USA
关键词
D O I
10.1053/jren.2002.35322
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Background: Novel classification nomenclature defining the type of malnutrition by the root cause of the hypoalbuminenia has been developing in the literature since 1999. As the classification of malnutrition became more definite in the literature, the need to assess the type of malnutrition, thereby the root cause(s) and initiate appropriate intervention(s), has become apparent. Methods: In September 1999, San Diego Dialysis began a continuous quality improvement (CQI) project to assess the root causes of hypoalbuminemia for patients with serum albumin level <3.5 g/dL. An extensive review of the literature was conducted on the subject of malnutrition, inflammation, and the acute-phase reaction. Findings: Two major groups of patients emerged: those consuming adequate protein and calories, yet presenting with hypoalbuminemia, and those suffering from a protein calorie deficit. Observation of the second group showed that although the monthly percentage of patients with hypoalbuminemia remained fairly constant, the names on the list changed from month to month. Conclusions: The CQI team developed a protocol and a unique nomenclature to classify the types of malnutrition, type I, type IIa, type IIb, or mixed, by adapting the definitions in the literature through clinical practice. Interventions were developed to address each classification of malnutrition. (C) 2002 by the National Kidney Foundation, Inc.
引用
收藏
页码:248 / 255
页数:8
相关论文
共 50 条
[1]  
Ando M, 1999, J AM SOC NEPHROL, V10, P2177
[2]   End-stage renal disease, atherosclerosis, and cardiovascular mortality: Is C-reactive protein the missing link? [J].
Arici, M ;
Walls, J .
KIDNEY INTERNATIONAL, 2001, 59 (02) :407-414
[3]  
Balzer C, 2001, DIALYSIS TRANSPLANT, V30, P390
[4]  
Bergström J, 2000, SEMIN DIALYSIS, V13, P163, DOI 10.1046/j.1525-139x.2000.00044.x
[5]   WHICH DIET FOR WHICH RENAL-FAILURE - MAKING SENSE OF THE OPTIONS [J].
BETO, JA .
JOURNAL OF THE AMERICAN DIETETIC ASSOCIATION, 1995, 95 (08) :898-903
[6]  
Bistrian B R, 2000, Nephrol Nurs J, V27, P616
[7]   Interaction between nutrition and inflammation in end-stage renal disease [J].
Bistrian, BR .
BLOOD PURIFICATION, 2000, 18 (04) :333-336
[8]   Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial [J].
Boaz, M ;
Smetana, S ;
Weinstein, T ;
Matas, Z ;
Gafter, U ;
Iaina, A ;
Knecht, A ;
Weissgarten, Y ;
Brunner, D ;
Fainaru, M ;
Green, MS .
LANCET, 2000, 356 (9237) :1213-1218
[9]   Reduction of the homocysteine plasma concentration by intravenously administered folinic acid and vitamin B12 in uraemic patients on maintenance haemodialysis [J].
Buccianti, G ;
Catena, FB ;
Patrosso, C ;
Corghi, E ;
Novembrino, C ;
Baragetti, I ;
Lando, G ;
De Franceschi, M ;
Maiolo, AT .
AMERICAN JOURNAL OF NEPHROLOGY, 2001, 21 (04) :294-299
[10]  
Crawford JF, 2001, DIALYSIS TRANSPLANT, V30, P512